EcoDrugPlus

Tubulin, Beta 6 Class V

Ensembl ID : ENSTRUG00000021687
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Type-2 Angiotensin Ii Receptor

Ensembl ID : ENSTRUG00000007325
Gene Symbol: LOC101068989
3 Cross references
185 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSTRUG00000007845
Gene Symbol: TYR
3 Cross references
202 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSTRUG00000009506
Gene Symbol: TYR
3 Cross references
198 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSTRUG00000009267
Gene Symbol: TH
4 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSTRUG00000009121
Gene Symbol: TYK2
2 Cross references
195 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSTRUG00000018474
Gene Symbol: TIE1
4 Cross references
205 Possible Orthologues:

Tyrosine-Protein Kinase Jak2-Like

Ensembl ID : ENSTRUG00000016857
Gene Symbol: LOC101068778
3 Cross references
194 Possible Orthologues:

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSTRUG00000002047
Gene Symbol: LOC101072875
4 Cross references
195 Possible Orthologues:

Tyrosine-Protein Kinase Fyna

Ensembl ID : ENSTRUG00000014739
Gene Symbol: LOC101063191
4 Cross references
191 Possible Orthologues:

Uncharacterized Loc101075685

Ensembl ID : ENSTRUG00000006912
Gene Symbol: LOC101075685
2 Cross references
214 Possible Orthologues:

Uncharacterized Loc101075732

Ensembl ID : ENSTRUG00000000915
Gene Symbol: LOC101075732
2 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).